In another clinical study, patients with hypertension and/or type 2 diabetes have a lower serum apelin level, along with cardiac remodeling, and primarily concentric left ventricle hypertrophy; moreover, there is a negative correlation of apelin with cardiac structural parameters such as left ventricle remodeling and left atrial size (62). This evidence concerns the gene APLN and type 2 diabetes mellitus.